PAX7 Antikörper (AA 301-505)
Kurzübersicht für PAX7 Antikörper (AA 301-505) (ABIN3026249)
Target
Alle PAX7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 301-505
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Recombinant human PAX7 protein corresponding to amino acids 301-505 was used as the immunogen for this antibody.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.\. FACS: 0.5-1 μg/million cells,IF: 0.5-1 μg/mL,WB: 0.5-1 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the PAX7 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- PAX7 (Paired Box 7 (PAX7))
-
Andere Bezeichnung
- PAX7
-
Hintergrund
- The PAX gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the PAX family of proteins have been linked to disease and cancer in humans. PAX7 is a protein specifically expressed in cultured satellite cell- derived myoblasts. In situ hybridization reveals that PAX7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding PAX7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma).
-
Gen-ID
- 5081
Target
-